Apposite Capital to exit Ulthera for potential 20x return

Merz, a specialty healthcare group, has agreed to buy Apposite Capital portfolio company Ulthera, which provides non-surgical lifting and tightening treatments. Apposite, the second largest shareholder in Ulthera, could make a return of more than 20x on its investment based on the terms of the agreement.

DealsNorth AmericaUSBriefs